Advertisement
Advertisement
Optiray

Optiray Drug Interactions

Manufacturer:

Liebel-Flarsheim

Distributor:

Biogenetech
Full Prescribing Info
Drug Interactions
Drugs which lower seizure threshold, especially phenothiazine derivatives, including those used for their antihistaminic or antinauseant properties, should not be used with Optiray.
Renal toxicity has been reported in a few patients with liver dysfunction who were given oral cholecystographic agents followed by intravascular contrast agents. Therefore administration of a contrast agent should be postponed by at least 48 hours following use of an oral cholecystographic agent.
Repeat Procedures: If in the clinical judgment of the physician a repeat examination is required, an interval of 5 days between procedures is recommended.
Special precautions, to be observed when performing specific diagnostic procedures, are listed in Dosage & Administration, under individual paragraphs pertaining to said specific procedures.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement